Search Results

Risk prediction models for antineoplastic-associated cardiotoxicity in treatment of breast cancer: A systematic review.

• Authors : Rodriguez, Ryan; Joseph, Honey; Macrito, Rosa

Subjects: THERAPEUTIC use of antineoplastic agents; CARDIOTOXICITY; ONLINE information services

• Source: American Journal of Health-System Pharmacy. 10/1/2023, Vol. 80 Issue 19, p1315-1325. 11p. 3 Charts.

Record details

Misconception on the duration of ado-trastuzumab emtansine treatment for HER2-positive early breast cancer.

• Authors : Chung, Clement¹

Subjects: *BREAST cancer surgery; *ADJUVANT chemotherapy; *TRASTUZUMAB

• Source: American Journal of Health-System Pharmacy. 5/15/2022, Vol. 79 Issue 10, p717-718. 2p.

Record details

Cyclin-dependent kinase 4/6 inhibitors for the management of advanced or metastatic breast cancer in women.

• Authors : Cersosimo, Robert J

Subjects: BREAST cancer prognosis; EPIDERMAL growth factor; AROMATASE inhibitors

• Source: American Journal of Health-System Pharmacy. Aug2019, Vol. 76 Issue 16, p1183-1202. 20p. 6 Charts.

Record details

Pharmacology and therapeutic use of trastuzumab in breast cancer.

• Authors : Treish, I; Schwartz, R; Lindley, C

• Source: American Journal of Health-System Pharmacy; November 2000, Vol. 57 Issue: 22 p2063-2076, 14p

Record details

Safety and efficacy of antiestrogens for prevention of breast cancer.

• Authors : Reddy, P; Chow, M S

• Source: American Journal of Health-System Pharmacy; July 2000, Vol. 57 Issue: 14 p1315-1322, 8p

Record details

Tamoxifen reduces risk of breast cancer in high-risk women.

• Source: American Journal of Health-System Pharmacy; May 1998, Vol. 55 Issue: 10 p978-981, 4p

Record details

Progress in breast cancer treatment: prevention, new therapies come to forefront.

• Authors : Miller, J L

• Source: American Journal of Health-System Pharmacy; November 1998, Vol. 55 Issue: 22 p2326-2330, 5p

Record details

Cost of managing anemia with and without prophylactic epoetin alfa therapy in breast cancer patients receiving combination chemotherapy.

• Authors : Meadowcroft, A M; Gilbert, C J; Maravich-May, D

• Source: American Journal of Health-System Pharmacy; September 1998, Vol. 55 Issue: 18 p1898-1902, 5p

Record details

Docetaxel: a taxoid for the treatment of metastatic breast cancer.

• Authors : Tankanow, R M

• Source: American Journal of Health-System Pharmacy; September 1998, Vol. 55 Issue: 17 p1777-1791, 15p

Record details

High-dose chemotherapy with stem-cell rescue for the treatment of breast cancer.

• Authors : McCauley, D L

• Source: American Journal of Health-System Pharmacy; March 1996, Vol. 53 Issue: 5 p521-534, 14p

Record details

Anastrozole: a selective aromatase inhibitor for the treatment of breast cancer.

• Authors : Higa, G M; alKhouri, N

• Source: American Journal of Health-System Pharmacy; March 1998, Vol. 55 Issue: 5 p445-452, 8p

Record details

Safety and tolerability of eribulin mesylate in patients with pretreated metastatic breast cancer.

• Authors : GOODIN, SUSAN; BARBOUR, SALLY; SONG, JAMES

Subjects: BREAST tumors; CANCER chemotherapy; METASTASIS

• Source: American Journal of Health-System Pharmacy. 12/15/2015, Vol. 72 Issue 24, p2150-2156. 7p. 4 Charts, 1 Graph.

Record details

Ado-trastuzumab emtansine for the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer.

• Authors : PATEL, KIKI CHANDNI; HAGEMAN, KELLY; COOPER, MARYANN R.

Subjects: ANTINEOPLASTIC agents; BREAST tumors; CLINICAL trials

• Source: American Journal of Health-System Pharmacy. 4/1/2014, Vol. 71 Issue 7, p537-548. 12p. 1 Diagram, 2 Charts.

Record details

Pertuzumab for the treatment of human epidermal growth factor receptor type 2-positive metastatic breast cancer.

• Authors : CHUNG, CLEMENT; LAM, MASHA S. H.

Subjects: THERAPEUTIC use of monoclonal antibodies; BREAST tumors; CLINICAL trials

• Source: American Journal of Health-System Pharmacy. 9/15/2013, Vol. 70 Issue 18, p1579-1587. 9p. 1 Diagram, 1 Chart.

Record details

Exemestane for primary prevention of breast cancer in postmenopausal women.

• Authors : Yang Zhang (AUTHOR); Simondsen, Katherine (AUTHOR); Kolesar, Jill M. (AUTHOR)

• Source: American Journal of Health-System Pharmacy. 8/15/2012, Vol. 69 Issue 16, p1384-1388. 5p.

Record details

Eribulin mesylate: A novel halichondrin B analogue for the treatment of metastatic breast cancer.

• Authors : McBride, Ali; Butler, Sara K.

Subjects: ANTINEOPLASTIC agents; BREAST tumors; DRUG side effects

• Source: American Journal of Health-System Pharmacy. 5/1/2012, Vol. 69 Issue 9, p745-755. 11p. 1 Diagram, 3 Charts, 1 Graph.

Record details

Clinical and economic benefits of aromatase inhibitor therapy in early-stage breast cancer.

• Authors : Glück, Stefan; Gorouhi, Fariborz

Subjects: DRUG side effects; DISEASE relapse prevention; BREAST tumors

• Source: American Journal of Health-System Pharmacy. 9/15/2011, Vol. 68 Issue 18, p1699-1706. 8p. 1 Diagram, 3 Charts.

Record details

Current combination chemotherapy regimens for metastatic breast cancer.

• Authors : Schwartz, Joanna

Subjects: COMBINATION drug therapy; BREAST cancer treatment; ANTINEOPLASTIC agents

• Source: American Journal of Health-System Pharmacy. 12/2/2009, Issue S6, pS3-S8. 6p. 2 Graphs.

Record details

Use of erythropoietin-stimulating agents in breast cancer patients: A risk review.

• Authors : Crouch, Zachary; Hermes DeSantis, Evelyn R.

Subjects: ANEMIA treatment; ERYTHROCYTE disorders; RED blood cell transfusion

• Source: American Journal of Health-System Pharmacy. 7/1/2009, Vol. 66 Issue 13, p1180-1185. 6p.

Record details

Chemoprevention of breast cancer.

• Authors : Thomsen, Annelise; Kolesar, Jill M.

Subjects: BREAST cancer risk factors; FAMILIAL diseases; ESTROGEN

• Source: American Journal of Health-System Pharmacy. 12/1/2008, Vol. 65 Issue 23, p2221-2228. 8p. 3 Charts.

Record details

Ixabepilone: A novel microtubule-stabilizing agent for the treatment of metastatic breast cancer.

• Authors : Goodin, Susan

Subjects: BREAST cancer treatment; MICROTUBULES; DRUG resistance

• Source: American Journal of Health-System Pharmacy. 11/1/2008, Vol. 65 Issue 21, p2017-2026. 10p. 1 Diagram, 3 Charts.

Record details

Lapatinib: A dual tyrosine kinase inhibitor for metastatic breast cancer.

• Authors : Paul, Betsy; Trovato, James A.; Thompson, Jennifer

Subjects: PROTEIN-tyrosine kinase inhibitors; BREAST cancer treatment; METASTASIS

• Source: American Journal of Health-System Pharmacy. 9/15/2008, Vol. 65 Issue 18, p1703-1710. 8p. 1 Diagram, 2 Charts.

Record details

Low-dose filgrastim in patients with breast cancer treated with docetaxel, doxorubicin, and cyclophosphamide.

• Authors : Ip, Eric J.; Lee-Ma, Annette; Troxell, Lawrence S.

Subjects: BREAST cancer patients; FEBRILE neutropenia; DRUG therapy

• Source: American Journal of Health-System Pharmacy. 8/15/2008, Vol. 65 Issue 16, p1552-1555. 4p. 1 Chart.

Record details

Caring for the treatment-experienced breast cancer patient: The pharmacist's role.

• Authors : Barbour, Sally Yowell

Subjects: BREAST cancer; CANCER treatment; PHARMACIST-patient relationships

• Source: American Journal of Health-System Pharmacy. 5/15/2008 Supplement, Vol. 65 Issue S3, pS16-S22. 7p. 3 Charts.

Record details

Treatment-experienced breast cancer.

Subjects: CANCER treatment; BREAST cancer; CANCER in womenUNITED States

• Source: American Journal of Health-System Pharmacy. 5/15/2008 Supplement, Vol. 65 Issue S3, pS4-S9. 6p. 1 Diagram, 1 Graph.

Record details

Gene-expression assays: New tools to individualize treatment of early-stage breast cancer.

• Authors : Dobbe, Elizabeth; Gurney, Kristen; Kiekow, Sara

Subjects: CANCER diagnosis; BREAST cancer; THERAPEUTICS

• Source: American Journal of Health-System Pharmacy. 1/1/2008, Vol. 65 Issue 1, p23-28. 6p. 3 Diagrams.

Record details

Antiemetic care for patients with breast cancer: Focus on drug interactions and safety concerns.

• Authors : Georgy, Angela; Neceskas, Jacalyn; Goodin, Susan

Subjects: ANTIEMETICS; BREAST cancer patients; DRUG interactions

• Source: American Journal of Health-System Pharmacy. 11/1/2007, Vol. 64 Issue 21, p2227-2236. 10p. 3 Charts.

Record details

Role of trastuzumab in adjuvant therapy for locally invasive breast cancer.

• Authors : Kabe, Katie L.; Kolesar, Jill M.

Subjects: TRASTUZUMAB; BREAST cancer; ADJUVANT treatment of cancer

• Source: American Journal of Health-System Pharmacy. 3/15/2006, Vol. 63 Issue 6, p527. 7p. 3 Diagrams, 2 Charts.

Record details

Adjuvant use of aromatase inhibitors in postmenopausal women with breast cancer.

• Authors : Michaud LB (AUTHOR)

• Source: American Journal of Health-System Pharmacy. 2/1/2005, Vol. 62 Issue 3, p266-273. 8p.

Record details

Antiemetic effectiveness of ondansetron and granisetron in patients with breast cancer treated with cyclophosphamide.

• Authors : Dempsey, Cindy L; Coop, Andrew J.; Shillington, Alicia

Subjects: ANTIEMETICS; CANCER patients; BREAST cancer

• Source: American Journal of Health-System Pharmacy. 4/15/2004, Vol. 61 Issue 8, p781-786. 6p.

Record details

Breast-cancer risk: higher with estrogen-progestin than estrogen alone.

• Authors : Miller, J L

• Source: American Journal of Health-System Pharmacy; April 2000, Vol. 57 Issue: 7 p635-636, 2p

Record details

Novel combinations for treating metastatic breast cancer: Improving the odds.

Subjects: *COMBINATION drug therapy; *BREAST cancer treatment

• Source: American Journal of Health-System Pharmacy. 12/2/2009, Issue S6, pS15-S17. 3p.

Record details

Novel combinations for treating metastatic breast cancer: Improving the odds.

• Authors : Schwartz, Joanna¹ ; Wong, Serena T.²

Subjects: *BREAST cancer research; *BREAST cancer treatment; *DRUG efficacy

• Source: American Journal of Health-System Pharmacy. 12/2/2009, Issue S6, pS1-S2. 2p.

Record details

Treatment-experienced breast cancer: New pathways for improving survival.

• Authors : Michaud, Laura Boehnke¹

Subjects: *BREAST cancer; *CANCER treatment; *CANCER in women

• Source: American Journal of Health-System Pharmacy. 5/15/2008 Supplement, Vol. 65 Issue S3, pS23-S24. 2p.

Record details

Treatment-experienced breast cancer: New pathways for improving survival: Introduction.

• Authors : Waddell, J. Aubrey¹

Subjects: *BREAST cancer; *CANCER treatment

• Source: American Journal of Health-System Pharmacy. 5/15/2008 Supplement, Vol. 65 Issue S3, pS2-S3. 2p.

Record details

Raloxifene examined for breast cancer prevention.

• Authors : Young, Donna

Subjects: *RALOXIFENE; *BREAST cancer; *CANCER preventionUNITED StatesUNITED States. Food & Drug Administration

• Source: American Journal of Health-System Pharmacy. 9/1/2007, Vol. 64 Issue 17, p1774-1776. 2p.

Record details

Experts say preoperative chemotherapy often best for breast cancer.

• Authors : Traynor, Kate

Subjects: *CONFERENCES & conventions; *PREOPERATIVE care; *DRUG therapyBETHESDA (Md.); MARYLANDNATIONAL Cancer Institute (U.S.)

• Source: American Journal of Health-System Pharmacy. 5/1/2007, Vol. 64 Issue 9, p906-910. 3p.

Record details

New data refine role of adjuvant tamoxifen in early breast cancer.

• Source: American Journal of Health-System Pharmacy; January 1996, Vol. 53 Issue: 2 p123-124, 2p

Record details

Panel evaluates adjuvant-therapy options for breast cancer.

• Authors : Miller, J L

• Source: American Journal of Health-System Pharmacy; December 2000, Vol. 57 Issue: 24 p2255-2255, 1p

Record details

Epirubicin approved for breast cancer treatment.

• Authors : Miller, J L

• Source: American Journal of Health-System Pharmacy; November 1999, Vol. 56 Issue: 21 p2177-2177, 1p

Record details

Report examines strategies for reducing breast cancer risk.

• Authors : Miller, J L

• Source: American Journal of Health-System Pharmacy; July 1999, Vol. 56 Issue: 13 p1298-1298, 1p

Record details

Studies of high-dose chemotherapy with stem cell support for breast cancer.

• Source: American Journal of Health-System Pharmacy; May 1999, Vol. 56 Issue: 10 p940-940, 1p

Record details

Breast cancer studies yield mixed results on high-dose chemotherapy with stem cell support.

• Authors : Miller, S L

• Source: American Journal of Health-System Pharmacy; May 1999, Vol. 56 Issue: 10 p939-939, 1p

Record details

Exemestane: treatment of breast cancer with selective inactivation of aromatase.

• Authors : Higa GM (AUTHOR)

• Source: American Journal of Health-System Pharmacy. 11/15/2002, Vol. 59 Issue 22, p2194-2202. 9p.

Record details

Exemestane:Treatment of breast cancer with selective inactivation of aromatase.

• Authors : Higa, Gerald M.

Subjects: *BREAST cancer; *CANCER treatment; *ANTINEOPLASTIC agents

• Source: American Journal of Health-System Pharmacy. 11/15/2002, Vol. 59 Issue 22, p2194. 8p.

Record details

Ado-trastuzumab emtansine approved for advanced breast cancer.

• Authors : Traynor, Kate

Subjects: ANTINEOPLASTIC agents; BREAST tumors; DRUG labeling

• Source: American Journal of Health-System Pharmacy. 4/1/2013, Vol. 70 Issue 7, p562-562. 2/3p.

Record details

FDA approves pertuzumab for breast cancer.

• Authors : Traynor, Kate

Subjects: BREAST tumors; COMBINATION drug therapy; DRUG allergy

• Source: American Journal of Health-System Pharmacy. 7/15/2012, Vol. 69 Issue 14, p1178-1178. 2/3p.

Record details

Eribulin approved for advanced breast cancer.

• Authors : Traynor, Kate

Subjects: ANTINEOPLASTIC agents; BREAST tumors; METASTASISUNITED States

• Source: American Journal of Health-System Pharmacy. 1/1/2011, Vol. 68 Issue 1, p6-6. 2/3p.

Record details

FDA approves new breast cancer treatment.

• Authors : Thompson, Cheryl A.

Subjects: BRISTOL-Myers Squibb Co.; PRODUCT management; BREAST cancerUNITED States

• Source: American Journal of Health-System Pharmacy. 12/1/2007, Vol. 64 Issue 23, p2406-2406. 2/3p.

Record details